Unknown

Dataset Information

0

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II.

ABSTRACT: Tankyrase 1 and 2 (TNKS1/2) catalyze post-translational modification by poly-ADP-ribosylation of a plethora of target proteins. In this function, TNKS1/2 also impact the WNT/β-catenin and Hippo signaling pathways that are involved in numerous human disease conditions including cancer. Targeting TNKS1/2 with small-molecule inhibitors shows promising potential to modulate the involved pathways, thereby potentiating disease intervention. Based on our 1,2,4-triazole-based lead compound 1 (OM-1700), further structure-activity relationship analyses of East-, South- and West-single-point alterations and hybrids identified compound 24 (OM-153). Compound 24 showed picomolar IC50 inhibition in a cellular (HEK293) WNT/β-catenin signaling reporter assay, no off-target liabilities, overall favorable absorption, distribution, metabolism, and excretion (ADME) properties, and an improved pharmacokinetic profile in mice. Moreover, treatment with compound 24 induced dose-dependent biomarker engagement and reduced cell growth in the colon cancer cell line COLO 320DM.

SUBMITTER: Leenders RGG 

PROVIDER: S-EPMC8713164 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Tankyrase 1 and 2 (TNKS1/2) catalyze post-translational modification by poly-ADP-ribosylation of a plethora of target proteins. In this function, TNKS1/2 also impact the WNT/β-catenin and Hippo signaling pathways that are involved in numerous human disease conditions including cancer. Targeting TNKS1/2 with small-molecule inhibitors shows promising potential to modulate the involved pathways, thereby potentiating disease intervention. Based on our 1,2,4-triazole-based lead compound <b>1</b> (OM-  ...[more]

Similar Datasets

Unknown Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor.
| S-EPMC8008393 | biostudies-literature
Unknown Dichloridotetra-kis-(1H-1,2,4-triazole-κN(4))copper(II).
| S-EPMC3343794 | biostudies-literature
Unknown Diaqua-bis(1H-1,2,4-triazole-3-carboxyl-ato)cadmium(II).
| S-EPMC2915071 | biostudies-literature
Unknown Bis[triaqua-(1H-1,2,4-triazole-3,5-dicarboxyl-ato-κO,N)copper(II)] di-μ-aqua-bis-[diaqua-(1H-1,2,4-triazole-3,5-dicarboxyl-ato-κO,N)copper(II)].
| S-EPMC2977176 | biostudies-literature
Unknown Nitrato(1,10-phenanthroline)(1H-1,2,4-triazole-3-carboxyl-ato)copper(II).
| S-EPMC2960337 | biostudies-literature
Unknown Chlorido(1,10-phenanthroline)(1H-1,2,4-triazole-3-carboxyl-ato)copper(II).
| S-EPMC2914951 | biostudies-literature
Unknown A new copper(II) complex based on 1-[(1H-benzotriazol-1-yl)meth-yl]-1H-1,2,4-triazole.
| S-EPMC3089299 | biostudies-literature
Unknown catena-Poly[[dibromidozinc(II)]-μ-4-(3-pyrid-yl)-4H-1,2,4-triazole].
| S-EPMC3007524 | biostudies-literature
Unknown catena-Poly[[triaqua-zinc(II)]-μ-1H-1,2,4-triazole-3,5-dicarboxyl-ato].
| S-EPMC2960531 | biostudies-literature
Unknown Poly[dichloridobis[μ-1-(4-pyridyl-meth-yl)-1,2,4-triazole]cadmium(II)].
| S-EPMC2983120 | biostudies-literature